High performance liquid chromatography assay for determination of moxifloxacin in human plasma

Luong Thi My Hanh, Nguyen Thi Minh Diep, Pham Thi Ngoc Mai, Nguyen Xuan Truong
Author affiliations

Authors

  • Luong Thi My Hanh Faculty of Chemistry, Hanoi University of Science, VNU Ha Noi, 19 Le Thanh Tong street, Hoan Kiem, Ha Noi, Viet Nam
  • Nguyen Thi Minh Diep Department of Drug Quality Control, Phu Tho Medical and Pharmacy College, No. 2201, Hung Vuong street, Viet Tri, Phu Tho, Viet Nam
  • Pham Thi Ngoc Mai Faculty of Chemistry, Hanoi University of Science, VNU Ha Noi, 19 Le Thanh Tong street, Hoan Kiem, Ha Noi, Viet Nam
  • Nguyen Xuan Truong School of Chemical Engineering, Hanoi University of Science and Technology, No. 1, Dai Co Viet, Hai Ba Trung, Ha Noi, Viet Nam

DOI:

https://doi.org/10.15625/2525-2518/57/3/13362

Keywords:

Moxifloxacin, protein precipitation, tricloroacetic acid, HPLC method, human plasma

Abstract

A simple reversed phase HPLC method with UV detection has been successfully developed and validated for determination of moxifloxacin in human plasma. The sample pretreatment involves only single-step protein precipitation with tricloroacetic acid. Moxifloxacin was measured in plasma using a validated HPLC method with UV detector at 295 nm, C18 column (25cm×4.5mm, 5µm), a mixture of phosphate buffer pH 4.0 and acetonitrile (70:30, v/v) as mobile phase at a flow rate of 0.8 ml/min. Retention time of moxifloxacin was found to be 7.4 min. The mean recovery for the drug was obtained 97.30%. The calibration curve was linear over the concentration range of 0.3 to 25.0 µg/mL with coefficient correlation of 0.9991. This method was successfully applied for therapeutic drug monitoring.

Downloads

Download data is not yet available.

References

(1) R. Ronald, A.; Low, D. Fluoroquinolone Antibiotics.; Birkhauser Boston Springer: Cambridge; Secaucus, 2012.

(2) The Quinolones, 3rd ed.; Andriole, V. T., Ed.; Academic Press: San Diego, 2000.

(3) Appelbaum, P. C.; Hunter, P. A. The Fluoroquinolone Antibacterials: Past, Present and Future Perspectives. Int. J. Antimicrob. Agents 2000, 16 (1), 5–15.

(4) Labandjurdjevic, A.; Jelikicstankov, M.; Djurdjevic, P. Optimization and Validation of the Direct HPLC Method for the Determination of Moxifloxacin in Plasma. J. Chromatogr. B 2006, 844 (1), 104–111. https://doi.org/10.1016/j.jchromb.2006.07.001. https://doi.org/10.1016/j.jchromb.2006.07.001.">

(5) Tatar Ulu, S. High-Performance Liquid Chromatography Assay for Moxifloxacin: Pharmacokinetics in Human Plasma. J. Pharm. Biomed. Anal. 2007, 43 (1), 320–324. https://doi.org/10.1016/j.jpba.2006.06.026. https://doi.org/10.1016/j.jpba.2006.06.026.">

(6) Hemanth Kumar, A. K.; Ramachandran, G. Simple and Rapid Liquid Chromatography Method for Determination of Moxifloxacin in Plasma. J. Chromatogr. B 2009, 877 (11–12), 1205–1208. https://doi.org/10.1016/j.jchromb.2009.02.042. https://doi.org/10.1016/j.jchromb.2009.02.042.">

(7) Hurtado, F. K.; Kaiser, M.; Tasso, L.; Dalla Costa, T. Fast and Sensitive RP-HPLC—Fluorescence Method for the Quantitative Analysis of Moxifloxacin in Rat Plasma and Its Application to a Preclinical Pharmacokinetic Study. Acta Chromatogr. 2016, 28 (2), 175–191. https://doi.org/10.1556/1326.2016.28.2.3. https://doi.org/10.1556/1326.2016.28.2.3.">

(8) Khan, F. U.; Nasir, F.; Iqbal, Z.; Khan, I.; Shahbaz, N.; Hassan, M.; Ullah, F. Simultaneous Determination of Moxifloxacin and Ofloxacin in Physiological Fluids Using High Performance Liquid Chromatography with Ultraviolet Detection. J. Chromatogr. B 2016, 1017–1018, 120–128. https://doi.org/10.1016/j.jchromb.2016.03.002. https://doi.org/10.1016/j.jchromb.2016.03.002.">

(9) Czyrski, A.; Sokół, A.; Szałek, E. HPLC Method for Determination of Moxifloxacin in Plasma and Its Application in Pharmacokinetic Analysis. J. Liq. Chromatogr. Relat. Technol. 2017, 40 (1), 8–12. https://doi.org/10.1080/10826076.2017.1280680. https://doi.org/10.1080/10826076.2017.1280680.">

(10) Wang, N.; Zhu, L.; Zhao, X.; Yang, W.; Sun, H. Improved HPLC Method for the Determination of Moxifloxacin in Application to a Pharmacokinetics Study in Patients with Infectious Diseases. ISRN Pharmacol. 2013, 2013, 1–7. https://doi.org/10.1155/2013/462918. https://doi.org/10.1155/2013/462918.">

(11) Xu, Y. H.; Li, D.; Liu, X. Y.; Li, Y. Z.; Lu, J. High Performance Liquid Chromatography Assay with Ultraviolet Detection for Moxifloxacin: Validation and Application to a Pharmacokinetic Study in Chinese Volunteers. J. Chromatogr. B 2010, 878 (32), 3437–3441. https://doi.org/10.1016/j.jchromb.2010.10.024. https://doi.org/10.1016/j.jchromb.2010.10.024.">

(12) Trần Cao Sơn. Thẩm Định Phương Pháp Trong Phân Tích Hóa Học & vi Sinh Vật; Nhà xuất bản Khoa học và Kỹ thuật, 2010.

Downloads

Published

04-06-2019

How to Cite

[1]
L. T. M. Hanh, N. T. M. Diep, P. T. Ngoc Mai, and N. X. Truong, “High performance liquid chromatography assay for determination of moxifloxacin in human plasma”, Vietnam J. Sci. Technol., vol. 57, no. 3, pp. 336–343, Jun. 2019.

Issue

Section

Materials